HCM
GILD icon

Hamlin Capital Management’s Gilead Sciences GILD Stock Holding History

Hamlin Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-632,397
Closed -$48.7M – 31
2020
Q2 		$48.7M Buy
632,397
+101,172
+19% +$7.75M 2.6% 23
2020
Q1 		$39.7M Sell
531,225
-221,517
-29% -$15.3M 2.38% 22
2019
Q4 		$48.9M Buy
752,742
+5,822
+0.8% +$379K 2.03% 29
2019
Q3 		$47.3M Buy
746,920
+354,950
+91% +$23.2M 2.13% 27
2019
Q2 		$26.5M Buy
+391,970
New +$25.8M 1.14% 38

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Hamlin Capital Management's GILD Position: Q3 2020 in Review

Hamlin Capital Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 632,397 shares — an estimated $48.7M sold.

Hamlin Capital Management first reported a position in GILD in Q2 2019 and held it in 5 quarters. The position peaked at $48.9M in Q4 2019. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Hamlin Capital Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Hamlin Capital Management sold 632,397 Gilead Sciences shares in Q3 2020, an estimated $48.7M.
  • Hamlin Capital Management first reported a position in Gilead Sciences in Q2 2019 and held it in 5 quarters.
  • Hamlin Capital Management's Gilead Sciences position peaked at $48.9M in Q4 2019.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Hamlin Capital Management's 13F filing for Q3 2020, filed 13 Oct 2020.